CovidChloroV1, Main, Curation, bibRecord, 001735

Biggest COVID-19 trial tests repurposed drugs first.

Identifieur interne : 001735 ( Main/Curation ); précédent : 001734; suivant : 001736

Biggest COVID-19 trial tests repurposed drugs first.

Auteurs :

Source :

Nature biotechnology [ 1546-1696 ] ; 2020.

RBID : pubmed:32393915

Descripteurs français

KwdFr :
- Association médicamenteuse (MeSH), Azithromycine (usage thérapeutique), Betacoronavirus (MeSH), Dexaméthasone (usage thérapeutique), Essais cliniques adaptatifs comme sujet (MeSH), Essais contrôlés randomisés comme sujet (MeSH), Humains (MeSH), Hydroxychloroquine (usage thérapeutique), Infections à coronavirus (traitement médicamenteux), Lopinavir (usage thérapeutique), Norme de soins (MeSH), Pandémies (MeSH), Pneumopathie virale (traitement médicamenteux), Repositionnement des médicaments (MeSH), Ritonavir (usage thérapeutique), Royaume-Uni (MeSH).
MESH :
- traitement médicamenteux : Infections à coronavirus, Pneumopathie virale.
- usage thérapeutique : Azithromycine, Dexaméthasone, Hydroxychloroquine, Lopinavir, Ritonavir.
- Association médicamenteuse, Betacoronavirus, Essais cliniques adaptatifs comme sujet, Essais contrôlés randomisés comme sujet, Humains, Norme de soins, Pandémies, Repositionnement des médicaments, Royaume-Uni.
Wicri :
- geographic : Royaume-Uni.

English descriptors

KwdEn :
- Adaptive Clinical Trials as Topic (MeSH), Azithromycin (therapeutic use), Betacoronavirus (MeSH), COVID-19 (MeSH), Coronavirus Infections (drug therapy), Dexamethasone (therapeutic use), Drug Combinations (MeSH), Drug Repositioning (MeSH), Humans (MeSH), Hydroxychloroquine (therapeutic use), Lopinavir (therapeutic use), Pandemics (MeSH), Pneumonia, Viral (drug therapy), Randomized Controlled Trials as Topic (MeSH), Ritonavir (therapeutic use), SARS-CoV-2 (MeSH), Standard of Care (MeSH), United Kingdom (MeSH).
MESH :
- chemical , therapeutic use : Azithromycin, Dexamethasone, Hydroxychloroquine, Lopinavir, Ritonavir.
- geographic : United Kingdom.
- drug therapy : Coronavirus Infections, Pneumonia, Viral.
- Adaptive Clinical Trials as Topic, Betacoronavirus, COVID-19, Drug Combinations, Drug Repositioning, Humans, Pandemics, Randomized Controlled Trials as Topic, SARS-CoV-2, Standard of Care.

DOI: 10.1038/s41587-020-0528-x
PubMed: 32393915

Links toward previous steps (curation, corpus...)

to stream Main, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001735

Links to Exploration step

pubmed:32393915

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Biggest COVID-19 trial tests repurposed drugs first.</title>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32393915</idno>
<idno type="pmid">32393915</idno>
<idno type="doi">10.1038/s41587-020-0528-x</idno>
<idno type="wicri:Area/Main/Corpus">001735</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001735</idno>
<idno type="wicri:Area/Main/Curation">001735</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001735</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Biggest COVID-19 trial tests repurposed drugs first.</title>
</analytic>
<series><title level="j">Nature biotechnology</title>
<idno type="eISSN">1546-1696</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adaptive Clinical Trials as Topic (MeSH)</term>
<term>Azithromycin (therapeutic use)</term>
<term>Betacoronavirus (MeSH)</term>
<term>COVID-19 (MeSH)</term>
<term>Coronavirus Infections (drug therapy)</term>
<term>Dexamethasone (therapeutic use)</term>
<term>Drug Combinations (MeSH)</term>
<term>Drug Repositioning (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Hydroxychloroquine (therapeutic use)</term>
<term>Lopinavir (therapeutic use)</term>
<term>Pandemics (MeSH)</term>
<term>Pneumonia, Viral (drug therapy)</term>
<term>Randomized Controlled Trials as Topic (MeSH)</term>
<term>Ritonavir (therapeutic use)</term>
<term>SARS-CoV-2 (MeSH)</term>
<term>Standard of Care (MeSH)</term>
<term>United Kingdom (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Association médicamenteuse (MeSH)</term>
<term>Azithromycine (usage thérapeutique)</term>
<term>Betacoronavirus (MeSH)</term>
<term>Dexaméthasone (usage thérapeutique)</term>
<term>Essais cliniques adaptatifs comme sujet (MeSH)</term>
<term>Essais contrôlés randomisés comme sujet (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Hydroxychloroquine (usage thérapeutique)</term>
<term>Infections à coronavirus (traitement médicamenteux)</term>
<term>Lopinavir (usage thérapeutique)</term>
<term>Norme de soins (MeSH)</term>
<term>Pandémies (MeSH)</term>
<term>Pneumopathie virale (traitement médicamenteux)</term>
<term>Repositionnement des médicaments (MeSH)</term>
<term>Ritonavir (usage thérapeutique)</term>
<term>Royaume-Uni (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Azithromycin</term>
<term>Dexamethasone</term>
<term>Hydroxychloroquine</term>
<term>Lopinavir</term>
<term>Ritonavir</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en"><term>United Kingdom</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Azithromycine</term>
<term>Dexaméthasone</term>
<term>Hydroxychloroquine</term>
<term>Lopinavir</term>
<term>Ritonavir</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adaptive Clinical Trials as Topic</term>
<term>Betacoronavirus</term>
<term>COVID-19</term>
<term>Drug Combinations</term>
<term>Drug Repositioning</term>
<term>Humans</term>
<term>Pandemics</term>
<term>Randomized Controlled Trials as Topic</term>
<term>SARS-CoV-2</term>
<term>Standard of Care</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Association médicamenteuse</term>
<term>Betacoronavirus</term>
<term>Essais cliniques adaptatifs comme sujet</term>
<term>Essais contrôlés randomisés comme sujet</term>
<term>Humains</term>
<term>Norme de soins</term>
<term>Pandémies</term>
<term>Repositionnement des médicaments</term>
<term>Royaume-Uni</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Royaume-Uni</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32393915</PMID>
<DateCompleted><Year>2020</Year>
<Month>05</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>12</Month>
<Day>10</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1546-1696</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>38</Volume>
<Issue>5</Issue>
<PubDate><Year>2020</Year>
<Month>05</Month>
</PubDate>
</JournalIssue>
<Title>Nature biotechnology</Title>
<ISOAbbreviation>Nat Biotechnol</ISOAbbreviation>
</Journal>
<ArticleTitle>Biggest COVID-19 trial tests repurposed drugs first.</ArticleTitle>
<Pagination><MedlinePgn>510</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1038/s41587-020-0528-x</ELocationID>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016433">News</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Nat Biotechnol</MedlineTA>
<NlmUniqueID>9604648</NlmUniqueID>
<ISSNLinking>1087-0156</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004338">Drug Combinations</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C558899">lopinavir-ritonavir drug combination</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>2494G1JF75</RegistryNumber>
<NameOfSubstance UI="D061466">Lopinavir</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber>
<NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>7S5I7G3JQL</RegistryNumber>
<NameOfSubstance UI="D003907">Dexamethasone</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>83905-01-5</RegistryNumber>
<NameOfSubstance UI="D017963">Azithromycin</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>O3J8G9O825</RegistryNumber>
<NameOfSubstance UI="D019438">Ritonavir</NameOfSubstance>
</Chemical>
</ChemicalList>
<SupplMeshList><SupplMeshName Type="Protocol" UI="C000705127">COVID-19 drug treatment</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000075522" MajorTopicYN="N">Adaptive Clinical Trials as Topic</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017963" MajorTopicYN="N">Azithromycin</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003907" MajorTopicYN="N">Dexamethasone</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004338" MajorTopicYN="N">Drug Combinations</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058492" MajorTopicYN="Y">Drug Repositioning</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D061466" MajorTopicYN="N">Lopinavir</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019438" MajorTopicYN="N">Ritonavir</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D059039" MajorTopicYN="N">Standard of Care</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006113" MajorTopicYN="N" Type="Geographic">United Kingdom</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>5</Month>
<Day>13</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>5</Month>
<Day>13</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>5</Month>
<Day>15</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32393915</ArticleId>
<ArticleId IdType="doi">10.1038/s41587-020-0528-x</ArticleId>
<ArticleId IdType="pii">10.1038/s41587-020-0528-x</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001735 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 001735 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:32393915
   |texte=   Biggest COVID-19 trial tests repurposed drugs first.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/RBID.i   -Sk "pubmed:32393915" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidChloroV1

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021

	Serveur d'exploration COVID et hydrochloroquine
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration COVID et hydrochloroquine

Biggest COVID-19 trial tests repurposed drugs first.

Biggest COVID-19 trial tests repurposed drugs first.

Source :

Descripteurs français

English descriptors

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki